JT
BMRN icon

Jump Trading’s BioMarin Pharmaceuticals BMRN Stock Holding History

Jump Trading’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,000
Closed -$684K – 499
2015
Q2 		$684K Sell
5,000
-6,900
-58% -$855K 0.01% 383
2015
Q1 		$1.48M Buy
+11,900
New +$1.26M 0.05% 177

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jump Trading's BMRN Position: Q2 2019 in Review

Jump Trading sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2019, closing a stake of 4,444 shares — an estimated $395K sold.

Jump Trading first reported a position in BMRN in Q3 2014 and held it in 4 quarters. The position peaked at $603K in Q2 2015. 482 funds tracked by Wall St. Rank hold BMRN as of Q2 2019.

  • Jump Trading reported no remaining BioMarin Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Jump Trading sold 4,444 BioMarin Pharmaceuticals shares in Q2 2019, an estimated $395K.
  • Jump Trading first reported a position in BioMarin Pharmaceuticals in Q3 2014 and held it in 4 quarters.
  • Jump Trading's BioMarin Pharmaceuticals position peaked at $603K in Q2 2015.
  • 482 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.